Can in vitro assessment provide relevant end points for cognitive drug programs?

Bibliography

• Marrer E, Dieterle F. Promises of biomarkers in drug development–a reality check. Chem Biol Drug Des 2007;69(6):381-94
   PubMed Web of Science ®Google Scholar
• Pritchard JF, et al. Making better drugs: decision gates in non-clinical drug development. Nat Rev Drug Discov 2003;2(7):542-53
   PubMed Web of Science ®Google Scholar
• Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 2005;4(10):825-33
   PubMed Web of Science ®Google Scholar
• Ekins S, et al. Towards a new age of virtual ADME/TOX and multidimensional drug discovery. J Comput Aided Mol Des 2002;16(5-6):381-401
   PubMed Web of Science ®Google Scholar
• Sanger DJ, Joly D. Psychopharmacological strategies in the search for cognition enhancers. Pharmacopsychiatry 1990;23(Suppl 2):70-4
   PubMed Web of Science ®Google Scholar
• Delacour J, et al. Electrophysiological models for the study of cognition enhancers. Pharmacopsychiatry 1990;23(Suppl 2):90-3
   PubMed Web of Science ®Google Scholar
• Albensi BC. Models of brain injury and alterations in synaptic plasticity. J Neurosci Res 2001;65(4):279-83
   PubMed Web of Science ®Google Scholar
• Beck H, Goussakov IV, Lie A, et al. Synaptic plasticity in the human dentate gyrus. J Neurosci 2000;20(18):7080-6
   PubMed Web of Science ®Google Scholar
• Albensi BC, Alasti N, Mueller AL. Long-term potentiation in the presence of NMDA receptor antagonist arylalkylamine spider toxins. J Neurosci Res 2000;62(2):177-85
   PubMed Web of Science ®Google Scholar
• Danysz W, Parsons CG. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int J Geriatr Psychiatry 2003;18(Suppl 1):S23-32
   PubMed Web of Science ®Google Scholar
• Chazot PL. CP-101606 Pfizer Inc. Curr Opin Investig Drugs 2000;1(3):370-4
   PubMedGoogle Scholar
• Neves G, Cooke SF, Bliss TV. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat Rev Neurosci 2008;9(1):65-75
   PubMed Web of Science ®Google Scholar
• Bear MF, Malenka RC. Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol 1994;4(3):389-99
   PubMedGoogle Scholar
• Albensi BC, et al. Electrical stimulation protocols for hippocampal synaptic plasticity and neuronal hyper-excitability: are they effective or relevant? Exp Neurol 2007;204(1):1-13
   PubMed Web of Science ®Google Scholar
• Bliss T, Collinridge G, Morris R. Synaptic plasticity in the hippocampus. In: The Hippocampus Book. Anderson P, et al, editors. 2007, Oxford University Press: New York. p. 343-474
   Google Scholar
• Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993;361(6407):31-9
   PubMed Web of Science ®Google Scholar
• Martin SJ, Grimwood PD, Morris RG. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci 2000;23:649-711
   PubMed Web of Science ®Google Scholar
• Otto T, et al. Learning-related patterns of CA1 spike trains parallel stimulation parameters optimal for inducing hippocampal long-term potentiation. Hippocampus 1991;1(2):181-92
   PubMedGoogle Scholar
• Whitlock JR, et al. Learning induces long-term potentiation in the hippocampus. Science 2006;313(5790):1093-7
   PubMed Web of Science ®Google Scholar
• Pastalkova E, et al. Storage of spatial information by the maintenance mechanism of LTP. Science 2006;313(5790):1141-4
   PubMed Web of Science ®Google Scholar
• Malenka RC. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 1994;78(4):535-8
   PubMed Web of Science ®Google Scholar
• Teyler TJ. Use of brain slices to study long-term potentiation and depression as examples of synaptic plasticity. Methods 1999;18(2):109-16
   PubMed Web of Science ®Google Scholar
• Yang SN, Tang YG, Zucker RS. Selective induction of LTP and LTD by postsynaptic [Ca2+]i elevation. J Neurophysiol 1999;81(2):781-7
   PubMed Web of Science ®Google Scholar
• Dingledine R, et al. The glutamate receptor ion channels. Pharmacol Rev 1999;51(1):7-61
   PubMed Web of Science ®Google Scholar
• Albensi BC. The NMDA receptor/ion channel complex: a drug target for modulating synaptic plasticity and excitotoxicity. Curr Pharm Des 2007;13(31):3185-94
   PubMed Web of Science ®Google Scholar
• Albensi BC, et al. Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury? Am J Alzheimers Dis Other Demen 2004;19(5):269-74
   PubMedGoogle Scholar
• Schoepp DD, et al. Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist. Naunyn Schmiedebergs Arch Pharmacol 1998;358(2):175-80
   PubMed Web of Science ®Google Scholar
• Schoepp DD, Johnson BG. Pharmacology of metabotropic glutamate receptor inhibition of cyclic AMP formation in the adult rat hippocampus. Neurochem Int 1993;22(3):277-83
   PubMed Web of Science ®Google Scholar
• Kew JN, et al. Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site. J Neurosci 2000;20(11):4037-49
   PubMed Web of Science ®Google Scholar
• Watkins JC. The NMDA receptor concept: origins and development. 2nd edition. The NMDA receptor, Collingridge GL, Watkins JC, editors. 1994, New York: Oxford University Press
   Google Scholar
• Emptage N, Bliss TV, Fine A. Single synaptic events evoke NMDA receptor-mediated release of calcium from internal stores in hippocampal dendritic spines. Neuron 1999;22(1):115-24
   PubMed Web of Science ®Google Scholar
• Nicoll RA, Schmitz D. Synaptic plasticity at hippocampal mossy fibre synapses. Nat Rev Neurosci 2005;6(11):863-76
   PubMed Web of Science ®Google Scholar
• Harris EW, Cotman CW. Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl D-aspartate antagonists. Neurosci Lett 1986;70(1):132-7
   PubMed Web of Science ®Google Scholar
• Nicoll RA, Malenka RC. Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Ann N Y Acad Sci 1999;868:515-25
   PubMed Web of Science ®Google Scholar
• Abraham WC, Williams JM. Properties and mechanisms of LTP maintenance. Neuroscientist 2003;9(6):463-74
   PubMed Web of Science ®Google Scholar
• Reymann KG, Frey JU. The late maintenance of hippocampal LTP: requirements, phases, ‘synaptic tagging’ ‘late-associativity’ and implications. Neuropharmacology 2007;52(1):24-40
   PubMed Web of Science ®Google Scholar
• Miyashita T, et al. Networks of neurons, networks of genes: an integrated view of memory consolidation. Neurobiol Learn Mem 2008;89(3):269-84
   PubMed Web of Science ®Google Scholar
• Spilker B. Guide to clinical trials. 1996, Philadelphia: Lippincott-Raven
   Google Scholar
• Biomarkers Definitions Working Group, Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69(3):89-95
   PubMed Web of Science ®Google Scholar
• Shankar GM, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008;14(8):837-42
   PubMed Web of Science ®Google Scholar